Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Licht

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Oncogene|October 19, 2001
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AMLJ D Licht
The Journal of Clinical Investigation|November 7, 2001
Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?J D Licht
Genes & Development|May 14, 1999
Telomerase RNA function in recombinant Tetrahymena telomeraseJ D Licht, K Collins
Leukemia|August 30, 2002
The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding proteinS Takahashi, J D Licht
Blood|May 11, 1999
Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemiaA Melnick, J D Licht
Biochimica Et Biophysica Acta|May 16, 1996
The WT1 Wilms' tumor suppressor gene: how much do we really know?J C Reddy, J D Licht
Cancer Treatment Reports|January 1, 1987
Phase II trial of streptozocin in the treatment of advanced renal cell carcinomaJ D Licht, M B Garnick
Current Topics in Microbiology and Immunology|January 16, 2007
The PLZF gene of t (11;17)-associated APLM J McConnell, J D Licht
The Journal of Biological Chemistry|May 1, 1999
Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth controlM A English, J D Licht
The Journal of Biological Chemistry|December 15, 1995
The transcriptional effect of WT1 is modulated by choice of expression vectorJ C Reddy, S Hosono, J D Licht
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Oncogene|October 19, 2001
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AMLJ D Licht
The Journal of Clinical Investigation|November 7, 2001
Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?J D Licht
Genes & Development|May 14, 1999
Telomerase RNA function in recombinant Tetrahymena telomeraseJ D Licht, K Collins
Leukemia|August 30, 2002
The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding proteinS Takahashi, J D Licht
Blood|May 11, 1999
Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemiaA Melnick, J D Licht
Biochimica Et Biophysica Acta|May 16, 1996
The WT1 Wilms' tumor suppressor gene: how much do we really know?J C Reddy, J D Licht
Cancer Treatment Reports|January 1, 1987
Phase II trial of streptozocin in the treatment of advanced renal cell carcinomaJ D Licht, M B Garnick
Current Topics in Microbiology and Immunology|January 16, 2007
The PLZF gene of t (11;17)-associated APLM J McConnell, J D Licht
The Journal of Biological Chemistry|May 1, 1999
Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth controlM A English, J D Licht
The Journal of Biological Chemistry|December 15, 1995
The transcriptional effect of WT1 is modulated by choice of expression vectorJ C Reddy, S Hosono, J D Licht
Pageof 6